We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

ORTEXORTEX News
Tracking AVTX? Get live short interest, options flow, and signals on ORTEX.Sign up free →
AV

Avalo Therapeutics, Inc. (AVTX) short interest & options flow

NASDAQ

AVTX enters the week with one of the most extreme short positioning profiles in small-cap biotech — yet the borrow market tells a notably different story from what the headline short interest figure implies. Three-quarters of Avalo Therapeutics' free float is sold short. At 74.4% of float, short interest is not just elevated — it is deeply exceptional, ranking in roughly the 4th…

Latest pulse6 May 2026

AVTX cost to borrow surges 167% in one week to 1.54%, as short interest climbs to 30.7% of float ahead of earnings Friday.

$7.07-2.48% 1d-0.70% 1w-52.84% 1mClose: 4 Nov 2026
Short interest % of float
High
Live SI on ORTEX →
Cost to borrow
Rising
Live CTB on ORTEX →
Market cap
$379M
Next earnings
9 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 5 Nov 2026

ORTEX chart of Avalo Therapeutics, Inc. (AVTX) share price and short interest (% of free float), six months to November 4, 2026

Latest signals on AVTX

  • Cost to Borrow

    AVTX cost to borrow surges 167% in one week to 1.54%, as short interest climbs to 30.7% of float ahead of earnings Friday.

  • Utilization

    AVTX short interest utilization hits 91%, nearing the 100% maximum recorded over the past 52 weeks.

AVTX news and analysis

RSS

No long-form analysis yet for AVTX. Pulse alerts and the live data picture are available on ORTEX.

Open AVTX on ORTEX →

Want the live picture for AVTX?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AVTX — free to start on ORTEX.

Sign up for free →Open AVTX on ORTEX